Interleukins, inflammation, and mechanisms of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Vitamins and hormones

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0083-6729(06)74020-1PMID 17027528
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• β-amyloid protein structure determines the nature of cytokine release from rat microglia

  2007cited by this paper
• Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study.

  2006cited by this paper
• N-Methyl-d-aspartate Attenuates CXCR2-Mediated Neuroprotection through Enhancing the Receptor Phosphorylation and Blocking the Receptor Recycling

  2005cited by this paper
• Ibuprofen Suppresses Interleukin-1β Induction of Pro-Amyloidogenic α1-Antichymotrypsin to Ameliorate β-Amyloid (Aβ) Pathology in Alzheimer's Models

  2005cited by this paper
• Mechanisms of cell signaling and inflammation in Alzheimer's disease.

  2005cited by this paper
• CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid β‐peptide

  2005cited by this paper
• Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.

  2005cited by this paper
• Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role.

  2005cited by this paper
• Presenilin function and γ‐secretase activity

  2005cited by this paper
• The microglial "activation" continuum: from innate to adaptive responses

  2005cited by this paper
• Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer’s disease brain

  2005cited by this paper
• The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease.

  2005cited by this paper
• Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease.

  2005cited by this paper
• Dynamic Complexity of the Microglial Activation Response in Transgenic Models of Amyloid Deposition: Implications for Alzheimer Therapeutics

  2005cited by this paper
• Interleukin‐1β exacerbates and interleukin‐1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures

  2005cited by this paper
• Interleukin-1β enhances NMDA receptor-mediated current but inhibits excitatory synaptic transmission

  2005cited by this paper
• Frontotemporal dementia.

  2005cited by this paper
• Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer’s disease

  2005cited by this paper
• Macrophages in inflammation.

  2005cited by this paper
• Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures.

  2005cited by this paper
• IL-8 enhancement of amyloid-beta (Aβ1-42)-induced expression and production of pro-inflammatory cytokines and COX-2 in cultured human microglia

  2005cited by this paper
• Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation.

  2005cited by this paper
• Elevated interleukin‐6 levels in cerebrospinal fluid of vascular dementia patients

  2004cited by this paper
• Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease.

  2004cited by this paper
• Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease.

  2004cited by this paper
• Interleukin‐1: A master regulator of neuroinflammation

  2004cited by this paper
• IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors.

  2004cited by this paper
• Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.

  2004cited by this paper
• Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway.

  2004cited by this paper
• Sulindac improves memory and increases NMDA receptor subunits in aged Fischer 344 rats.

  2004cited by this paper
• Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.

  2004cited by this paper
• Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients

  2004cited by this paper
• Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3

  2004cited by this paper
• The metabolic syndrome, inflammation, and risk of cognitive decline.

  2004cited by this paper
• Alzheimer Patients Treated With an AchE Inhibitor Show Higher IL-4 and Lower IL-1β Levels and Expression in Peripheral Blood Mononuclear Cells

  2004cited by this paper
• A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.

  2004cited by this paper
• Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway.

  2004cited by this paper
• IL-10 and glucocorticoids inhibit Aβ(1–42)- and lipopolysaccharide-induced pro-inflammatory cytokine and chemokine induction in the central nervous system

  2003cited by this paper
• IL-10 and glucocorticoids inhibit Abeta(1-42)- and lipopolysaccharide-induced pro-inflammatory cytokine and chemokine induction in the central nervous system.

  2003cited by this paper
• Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active -Secretase Complex

  2003cited by this paper
• Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains

  2003cited by this paper
• Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain.

  2003cited by this paper
• Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease

  2003cited by this paper
• Interleukin-6, beta-amyloid peptide and NMDA interactions in rat cortical neurons.

  2003cited by this paper
• Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease.

  2003cited by this paper
• Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway

  2003cited by this paper
• Inflammatory Markers in Matched Plasma and Cerebrospinal Fluid from Patients with Alzheimer’s Disease

  2003cited by this paper
• Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity.

  2003cited by this paper
• Interleukin-6, β-amyloid peptide and NMDA interactions in rat cortical neurons

  2003cited by this paper
• Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

  2003cited by this paper
• Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses.

  2003cited by this paper
• Activation of the c-Jun N-terminal Kinase Signaling Cascade Mediates the Effect of Amyloid-β on Long Term Potentiation and Cell Death in Hippocampus

  2003cited by this paper
• Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex.

  2003cited by this paper
• Evidence That Nonsteroidal Anti-inflammatory Drugs Decrease Amyloid β42 Production by Direct Modulation of γ-Secretase Activity*

  2003cited by this paper
• Selective inhibition of Abeta42 production by NSAID R-enantiomers.

  2002cited by this paper
• The effect of IL4 +33C/T polymorphism on risk of Japanese sporadic Alzheimer's disease.

  2002cited by this paper
• NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line.

  2002cited by this paper
• Microglial activation and amyloid‐β clearance induced by exogenous heat‐shock proteins

  2002cited by this paper
• Noradrenergic Depletion Potentiates β-Amyloid-Induced Cortical Inflammation: Implications for Alzheimer's Disease

  2002cited by this paper
• Microglial Activation and β-Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice

  2002cited by this paper
• NF-κB mediates IL-1β-induced synthesis/release of α2-macroglobulin in a human glial cell line

  2002cited by this paper
• Axonal transport, tau protein, and neurodegeneration in Alzheimer’s disease

  2002cited by this paper
• Molecular basis of the cell specificity of cytokine action.

  2002cited by this paper
• Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins.

  2002cited by this paper
• Interleukin-1 beta exerts a myriad of effects in the brain and in particular in the hippocampus: analysis of some of these actions.

  2002cited by this paper
• Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells.

  2002cited by this paper
• The balance between IL-1 and IL-1Ra in disease.

  2002cited by this paper
• Peripheral inflammatory response in Alzheimer's disease and multiinfarct dementia.

  2002cited by this paper
• Selective inhibition of Aβ42 production by NSAID R‐enantiomers

  2002cited by this paper
• Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition.

  2002cited by this paper
• Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889 *1 allele.

  2001cited by this paper
• Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.

  2001cited by this paper
• Decreased Levels of Intrathecal Interleukin 1 Receptor Antagonist in Alzheimer’s Disease

  2001cited by this paper
• Rate of cognitive decline in AD is accelerated by the interleukin-1α −889 *1 allele

  2001cited by this paper
• Neuronal DNA damage correlates with overexpression of interleukin-1β converting enzyme in APPV717F mice

  2001cited by this paper
• Neuronal DNA damage correlates with overexpression of interleukin-1beta converting enzyme in APPV717F mice.

  2001cited by this paper
• Microglial interaction with β‐amyloid: Implications for the pathogenesis of Alzheimer's disease

  2001cited by this paper
• Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation.

  2001cited by this paper
• IL-4, IL-10 and IL-13 modulate Aβ(1–42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line

  2001cited by this paper
• Beta-amyloid, neuronal death and Alzheimer's disease.

  2001cited by this paper
• Inflammation, autotoxicity and Alzheimer disease.

  2001cited by this paper
• Immune function of astrocytes

  2001cited by this paper
• Control of synapse number by glia.

  2001cited by this paper
• A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

  2001cited by this paper
• Generation and characterization of immortalized human microglial cell lines: expression of cytokines and chemokines.

  2001cited by this paper
• Amyloid-β oligomers: their production, toxicity and therapeutic inhibition

  2001cited by this paper
• Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576.

  2001cited by this paper
• Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease

  2000cited by this paper
• Neuronal–Glial Interactions Mediated by Interleukin-1 Enhance Neuronal Acetylcholinesterase Activity and mRNA Expression

  2000cited by this paper
• Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

  2000cited by this paper
• Nasal administration of amyloid‐β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease

  2000cited by this paper
• Association of early‐onset Alzheimer's disease with an interleukin‐1α gene polymorphism

  2000cited by this paper
• Gene polymorphism affecting α1‐antichymotrypsin and interleukin‐1 plasma levels increases Alzheimer's disease risk

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.

  2000cited by this paper
• Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer's disease. Relationship with IL-6 concentrations.

  2000cited by this paper
• Association of interleukin‐1 gene polymorphisms with Alzheimer's disease

  2000cited by this paper
• Association of an interleukin 1α polymorphism with Alzheimer’s disease

  2000cited by this paper
• Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer's disease. Relationship with IL-6 concentrations.

  2000cited by this paper
• Association of an interleukin 1 alpha polymorphism with Alzheimer's disease.

  2000cited by this paper

• Dysregulated interleukin networks drive immune heterogeneity in Alzheimer’s disease: an immunogenomic approach to subgroup classification and predictive modeling

  2025cites this paper
• Metabolites associated with type 2 diabetes and Alzheimer’s disease trigger differential intracellular signaling responses in mouse primary neurons

  2025cites this paper
• Soluble Epoxide Hydrolase Inhibition Improves Alzheimer’s Disease Hallmarks: Correlation with Peripheral Inflammation and Gut Microbiota Modulation

  2025cites this paper
• Murine Non-Transgenic Models of Alzheimer’s Disease Pathology: Focus on Risk Factors

  2025cites this paper
• The AICD interactome: implications in neurodevelopment and neurodegeneration

  2024cites this paper
• Associations of neuroinflammatory IL-6 and IL-8 with brain atrophy, memory decline, and core AD biomarkers - In cognitively unimpaired older adults.

  2023cites this paper
• Association of Interleukin-6 and Interleukin-8 with Cognitive Decline in an Asian Memory Clinic Population

  2023cites this paper
• The Combined Effects of Physical Exercise and Cognitive Training on Gait Speed and Primary Motor Cortex Metabolism in Individuals with Mild Cognitive Impairment: A 1H-MRS Analysis

  2023cites this paper
• Pomegranate: A Source of Multifunctional Bioactive Compounds Potentially Beneficial in Alzheimer’s Disease

  2023cites this paper
• Could routine vaccinations prevent dementia?

  2023cites this paper
• Genetic Polymorphisms in Oxidative Stress and Inflammatory Pathways as Potential Biomarkers in Alzheimer’s Disease and Dementia

  2023cites this paper
• Astilbin attenuates neonatal postnatal immune activation-induced long-lasting cognitive impairment in adult mice

  2023cites this paper
• Anti-inflammatory potential of berberine-rich extract via modulation of inflammation biomarkers.

  2022cites this paper
• Amaryllidaceae, Lycopodiaceae Alkaloids and Coumarins—A Comparative Assessment of Safety and Pharmacological Activity

  2022cites this paper
• Alzheimer's Disease and Protein Kinases.

  2021cites this paper
• Elevation of inactive cleaved annexin A1 in the neocortex is associated with amyloid, inflammatory and apoptotic markers in neurodegenerative dementias.

  2021cites this paper
• Qisheng Wan formula ameliorates cognitive impairment of Alzheimer's disease rat via inflammation inhibition and intestinal microbiota regulation.

  2021cites this paper
• Obese but Fit: The Benefits of Fitness on Cognition in Obese Older Adults.

  2020cites this paper
• Synthesis and In Vitro Biological Activity Evaluation of Novel Imidazo [2,1-B][1,3,4] Thiadiazole as Anti-Alzheimer Agents

  2020cites this paper
• Effect of 6 Weeks Endurance Exercise on Hippocampal Pannexin-1 and NLRP-1 Protein Levels in Experimental Diabetic Male Wistar Rats

  2020cites this paper
• Blood Transcriptome Response to Environmental Metal Exposure Reveals Potential Biological Processes Related to Alzheimer's Disease

  2020cites this paper
• Association between anti-inflammatory interleukin-10 and executive function in African American women at risk for Alzheimer’s disease

  2020cites this paper
• Nanotechnology approaches for enhanced CNS delivery in treating Alzheimer's disease

  2019cites this paper
• Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease

  2019cites this paper
• Effect and Disease Indicative Role of Inflammation in Neurodegenerative Pathology: A Mechanistic Crosstalk of Promise and Dilemma

  2018cites this paper
• PGA: post-GWAS analysis for disease gene identification

  2018cites this paper
• The Role of Mental and Physical Activities against Development of Alzheimer′s disease in Socialized and Isolated Rats

  2017cites this paper
• Glial contributions to neurodegeneration in tauopathies

  2017influential citation
• Role of Pro-Inflammatory Cytokines and Vitamin D in Probable Alzheimer's Disease with Depression

  2017cites this paper
• PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation

  2017cites this paper
• Asiaticoside ameliorates β-amyloid-induced learning and memory deficits in rats by inhibiting mitochondrial apoptosis and reducing inflammatory factors

  2016cites this paper
• Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β

  2016cites this paper
• Chemotherapy-Induced Neurotoxicity: Evidence of a Protective Role of CC Homozygosis in the Interleukin-1β Gene-511 C>T Polymorphism

  2016cites this paper
• Mechanisms of tumor microenvironment in promoting metastasis

  2016cites this paper
• Myeloperoxidase: Bridging the gap in neurodegeneration.

  2016cites this paper
• [Pro-inflammatory cytokines in Alzheimer's disease].

  2016cites this paper
• Exploring Biomarkers for Alzheimer's Disease.

  2016cites this paper
• Shear-Sensitive Genes in Aortic Valve Endothelium

  2016cites this paper
• Anti-neuroinflammation activity of acetylpuerarin mediated by a PKC-δ-dependent caspase signaling pathway: in vivo and in vitro studies.

  2016cites this paper
• Physical training decreases susceptibility to pilocarpine-induced seizures in the injured rat brain.

  2016cites this paper
• Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer's disease: the NF-κB connection.

  2015cites this paper
• Could astrocytes be the primary target of an offending agent causing the primary degenerative diseases of the human central nervous system? A hypothesis.

  2015cites this paper
• Epistasis analysis links immune cascades and cerebral amyloidosis

  2015cites this paper
• Systemic lipopolysaccharide administration impairs retrieval of context-object discrimination, but not spatial, memory: Evidence for selective disruption of specific hippocampus-dependent memory functions during acute neuroinflammation.

  2015cites this paper
• Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment.

  2015cites this paper
• Characterization of inflammatory biomarkers and candidates for diagnosis of Alzheimer’s disease

  2014cites this paper
• Raised serum proinflammatory cytokines in Alzheimer's disease with depression.

  2014cites this paper
• Serum cytokine profile in Alzheimer's disease patients after ingestion of an antioxidant beverage.

  2014cites this paper
• Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice

  2013cites this paper
• Assessment of Platelet Indices in Patients with Neurodegenerative Diseases: Mean Platelet Volume Was Increased in Patients with Parkinson's Disease

  2013cites this paper
• Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines.

  2012cites this paper
• Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer’s disease

  2012cites this paper
• The association between aerobic fitness and executive function is mediated by prefrontal cortex volume.

  2012cites this paper
• Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show elevated baseline levels of secreted cytokines but resist stimulation with β-amyloid peptide.

  2012cites this paper
• Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease

  2012cites this paper
• Ratanasampil (Tibetan Medicine, RNSP) Reduces β-Amyloid Protein (Aβ) and Pro-Inflammatory Factor Levels and Improves Cognitive Functions in Mild-to-Moderate Alzheimer's Disease (AD) Patients Living at High Altitude

  2012cites this paper
• Marqueurs d'inflammation et risque d'atteintes cognitives et de démence chez l'aîné

  2012influential citation
• Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells.

  2011influential citation
• P1‐109: Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals

  2011cites this paper
• Brain-Reactive Autoantibodies Prevalent in Human Sera Increase Intraneuronal Amyloid-β1-42 Deposition

  2011cites this paper
• Novel Strains of Mice Deficient for the Vesicular Acetylcholine Transporter: Insights on Transcriptional Regulation and Control of Locomotor Behavior

  2011cites this paper
• Variantes génicas asociadas a neuroinflamación en la enfermedad de Alzheimer en Canarias

  2011cites this paper
• Proline-rich polypeptide complex (PRP) regulates secretion of inflammatory mediators by its effect on NF-kappaB activity.

  2010cites this paper
• P4‐063: Corticosteroids, but not Nsaids, are Associated With Less Alzheimer Neuropathology

  2010cites this paper
• Vascular mechanisms of AD pathogenesis: the putative role of a defective blood-brain barrier, serum Aβ42, and neuron-binding autoantibodies

  2010cites this paper
• Neuroglobin and Alzheimer's dementia: genetic association and gene expression changes.

  2010cites this paper
• A Versatile High Throughput Screening System for the Simultaneous Identification of Anti-Inflammatory and Neuroprotective Compounds

  2010cites this paper
• α-Tocopherol quinone inhibits β-amyloid aggregation and cytotoxicity, disaggregates preformed fibrils and decreases the production of reactive oxygen species, NO and inflammatory cytokines.

  2010cites this paper
• Applied Healthspan Engineering

  2010cites this paper
• Microglial activation depends on beta‐amyloid conformation: role of the formylpeptide receptor 2

  2010cites this paper
• Peripheral Cytokines and Chemokines in Alzheimer’s Disease

  2009cites this paper
• Molecular intervention in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease -- Neuropathology and behavior

  2009cites this paper
• MODULACIÓN MEDIANTE EJERCICIO FÍSICO DE LA EXPRESIÓN DE RECEPTORES Fc GAMMA Y MOLÉCULAS DE ADHESIÓN ENDOTELIAL, EN ADULTOS JÓVENES CON DIAGNOSTICO CLÍNICO DE SÍNDROME METABÓLICO

  2009cites this paper
• Cytokine-Induced Sickness Behavior and Depression

  2009cites this paper
• Amyloid Beta Transport and Effects on Permeability in a Human Brain Endothelial Cell Line

  2009cites this paper
• Ovine colostrum nanopeptide affects amyloid beta aggregation

  2009cites this paper
• Interleukin‐4 as a Neuromodulatory Cytokine

  2009cites this paper
• The effects of cardiovascular risk factors on cognitive compromise

  2009cites this paper
• Towards Retinoid Therapy for Alzheimer’s Disease

  2009cites this paper
• Amyloid-β-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation

  2009cites this paper
• Recent advances in our understanding of neurodegeneration

  2009cites this paper
• Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity.

  2009cites this paper
• [A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment].

  2008cites this paper
• Determination of Plaque and Tangle Density in Demyelinated versus Nondemyelinated Cortical Areas in Multiple Sclerosis

  2008cites this paper
• The role of oxidative stress and cholesterol in animal models of Alzheimer's disease

  2008cites this paper
• Cytokines in Synaptic Function

  2008cites this paper
• Role of Insulin Metabolism Disturbances in the Development of Alzheimer Disease: Mini Review

  2008cites this paper
• Cytokine IL‐1 beta but not IL‐1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary Islands, Spain

  2008cites this paper
• Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease.

  2008cites this paper
• Multiple sclerosis and Alzheimer's disease

  2008cites this paper
• Omega-3 fatty acid treatment in mild to moderate Alzheimer's disease : Results from the OmegAD study

  2008cites this paper
• Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker?

  2008cites this paper
• Redox Proteomics Identification of Oxidatively Modified Brain Proteins in Alzheimer's Disease and Mild Cognitive Impairment: Insights into the Progression of this Dementing Disorder

  2007cites this paper
• CNS and inflammation

  2007cites this paper
• Epidemiological study of risk factors in pediatric asthma

  2007cites this paper
• Transient receptor potential channels in Alzheimer's disease.

  2007cites this paper
• Exercise builds brain health: key roles of growth factor cascades and inflammation.

  2007cites this paper
• Research progress on mechanism related to Alzheimer’s disease treatment with Citri Reticulatae Pericarpium targeting inflammation

  year unknowncites this paper